One of the first steps in the infective cycle of an enveloped virus consists of the fusion of the viral and cellular membranes. This process is usually achieved as a result of membrane destabilization brought about by a viral fusion peptide located at the amino terminus of one of the viral envelope glycoproteins. Previous sequence similarity studies by Rodrlguez-Crespo et al. (Journal of General Virology 75, 637-639, 1994) have shown that a hydrophobic stretch in the amino-terminal sequence of the S protein of hepatitis B virus shares several characteristics with fusion peptides of retroviruses and paramyxoviruses. A 16 residue peptide with this sequence was synthesized and its interaction with liposomes characterized. This peptide was able to mediate vesicle aggregation, lipid mixing and liposome leakage in a pH dependent manner at concentrations ranging from 3"5 to 52.0 pM. These effects were specific for negatively charged phospholipid vesicles. The peptide was also able to haemolyse erythrocytes. This study supports the notion that the sequence might be important in the initial infective steps of this virus, interacting with the target membranes and bringing about their subsequent destabilization.
Introduction
The fusion of an enveloped virus with the host membrane is a key process in the life cycle of the virus. Fusion of the viral and cellular membranes allows the virus genome to enter the cytoplasm and carry out subsequent infective events (White, 1990 (White, , 1992 . The enveloped viruses may be divided into two groups according to the pH dependence of their fusogenic proteins, pH-dependent viruses fuse with the membranes of acidic endosomes. The mildly acidic pH of the endosome triggers rapid fusion usually exposing a fusogenic sequence buried within the structure of the envelope glycoprotein at neutral pH, and thus converting the protein to its fusionactive state (White, 1990) . This type of fusion is best characterized for the haemagglutinin protein of influenza virus, but has also been observed in other virus families. All orthomyxo-, toga-, rhabdo-and some retroviruses are usually considered to fuse in a pH-dependent manner. Internalization of these viruses is usually rapid and *Author for correspondence. Fax +34 1 3944159. e-mail pacog@solea.quim.ucm.es displays a sharp pH profile with midpoints ranging from 5.0 to 6-0. Since the envelope glycoproteins of these viruses need the mildly acidic pH environment of the endosomes to be converted to their fusogenic form, agents that raise the pH in these vesicles inhibit virus fusion and penetration. These agents are known as lysosomotropic agents and are weak bases, widely used nowadays to determine whether the acidic compartments are involved in a particular virus infection. The other group of enveloped viruses comprises those which possess proteins capable of fusing with the plasma membrane of the host cell at neutral pH. Viruses that display this pH-independent activity include herpes-, corona-, paramyxo-and some retroviruses. Viruses belonging to this second group undergo fusion with relatively slow kinetics, and the infection process is not inhibited by raising the endosome pH.
One of the envelope glycoproteins of most of the viruses mentioned above possesses an amino-terminal extension usually referred to as the fusion peptide. In those viruses that enter the cell through receptormediated endocytosis, the fusion peptide is exposed after the conformational change induced by the acidic pH. However, in those viruses capable of fusing with the 0001-2827 © 1995 SGM L Rodriguez-Crespo and others plasma membrane at neutral pH, the fusion peptide is frequently hidden and only after interaction of another glycoprotein with a cellular receptor does this aminoterminal sequence become exposed and perform the cellular membrane destabilization.
The destabilization of the target cell and virus membrane lipid bilayers at the point of virus-cell adhesion may be a critical step in membrane fusion. Thus, the ability of synthetic peptides that correspond to these sequences to penetrate into membranes and destabilize them, as well as the requirements for particular amino acid sequences and peptide structure for this function, can reveal some of the molecular mechanisms of membrane fusion mediated by viral fusion proteins. Synthetic peptides corresponding to the amino-terminal sequence of several viral glycoproteins have proved to be useful in order to ascertain the role of these peptide stretches in terms of membrane-membrane interactions during the initial infective steps (Diizgtines & Shavnin, 1992) . In this regard, amino-terminal peptides of influenza haemagglutinin (HA 2) have been widely used to study their interaction with liposomes and they have shown a pH dependence similar to that of intact virus (Lear & DeGrado, 1987; Murata et al., 1987) . Using this same approach, it has been shown that the 25 amino acid peptide corresponding to the amino terminus of the vesicular stomatitis virus envelope glycoprotein (G) causes haemolysis of sheep erythrocytes over a pH range similar to that observed for the virus on induction of cell~cell fusion, haemolytic activities and virus-cell fusion (Schlegel & Wade, 1984) . There have been several reports on interactions with lipid of peptides corresponding to the amino-terminal sequence of human immunodeficiency virus (HIV) gp41 emphasizing its importance during the initial infective steps (Martin et al., 1991 (Martin et al., , 1993 .
Hepatitis B virus (HBV), the prototype member of the hepadnavirus family (hepatotropic DNA virus), is a small enveloped DNA virus which causes acute and chronic liver diseases in humans. Related viruses have also been isolated from ducks (DHBV), herons (HHBV), woodchucks (WHB) and ground squirrels (GSHV) (see Ganem & Varmus, 1987 , for a review). HBV possesses three envelope glycoproteins (S, M and L proteins) that share the same 226 amino acids that make up the carboxy-terminal sequence of the S protein (Peterson, 1987; Heermann & Gerlich, 1991) . The S (small) protein is a hydrophobic membrane protein that has several putative a-helical regions interacting with the viral membrane (Guerrero et al., 1988; Stirk et al., 1992) . The M (medium) and L (large) proteins possess aminoterminal extensions of 55 and 163 (or 174, depending on the viral subtype) hydrophilic amino acids referred to as preS domains. These are believed to be surface exposed domains (Peterson, 1987 , Guerrero et al., 1988 although more recent data indicate that approximately half of them are internal in natural virions (Bruss et al., 1994) .
It has been hypothesized that the fusion sequence of HBV is located at the amino end of the S domain (Gerlich et al., 1993; Rodriguez-Crespo et al., 1994a) . Sequence analysis of the S protein reveals a short hydrophobic amino-terminal stretch which shows a high degree of similarity with known fusogenic peptides from other viruses. This sequence also appears to be highly conserved within the hepadnavirus family (RodriguezCrespo et al., 1994a) . A synthetic peptide comprising the first 16 amino acids of the S protein interacts with liposomes in a pH-dependent manner as demonstrated by use of sucrose density centrifugation (Rodr/guezCrespo et al., 1994b) . In this work we have studied the interaction of this synthetic peptide with phospholipid vesicles by employing a variety of fluorescent assays; the results are discussed in terms of the interaction of this sequence with the target membrane during the initial infective steps.
Methods
Reagents. Bovine brain phosphatidylserine (PS), N-(7-nitro-2,1,3-benzoxadiazol-4-yl)dimyristoylphosphatidylethanolamine (NBD-PE) and N-(lissamine rhodamine B sulphonyl)diacylphosphatidylethanolamine (Rh-PE) were provided by Avanti Polar Lipids. Soybean asolectin phospholipids were purified from type II soybean asolectin (Sigma) by adsorption chromatography on an activated silica-gel column in chloroform. The major components of asolectin phospholipids are: phosphatidylethanolamine (39%), phosphatidylcholine (PC) (24%) and phosphatidylserine (19%) (Papini et al., 1987) . 8-Aminonaphthalene-l,3,6-trisulphonic acid (ANTS) and p-xylenebis-(pyridinium) bromide (DPX) were obtained from Molecular Probes. Triton X-100 was purchased from Boehringer Mannheim.
Peptide synthesis. A 16 amino acid peptide covering the aminoterminal region of the S protein (sequence: Met-Glu-As~II~ Th~Se~Gly-Phe-Leu-Gly-Pro Le~Le~Va~Leu-Gln) was synthesized as the carboxy-terminal amide on an automated multiple peptide synthesizer (AMS 422, Abimed) using a solid-phase procedure and standard Fmoc chemistry in a base of 25 lamol. The synthesis was carried out on an N-ct-Fmoc-DMP resin [4-(2',4'-dimethoxyphenylFmoc-aminomethyl)phenoxy resin (Novabiochem)] with Fmoc-protected amino acids activated in situ with PyBOP (benzotriazole-l-yloxy-tris-pyrrolidinophosphonium hexafluorophosphate) in the presence of N-methylmorpholine and 20 % piperidine/dimethylformamide for deprotection. The protecting side-chain groups were as follows: A sn and Gln (Trt), Glu (OtBu), Ser and Thr (tBu). Peptides were cleaved from the resin with 82.5 % trifluoroacetic acid, and 5 % phenol, 5 % water, 5 % thioanisole, 2.5 % ethane dithiol as scavenger (King et al., 1990) , precipitated and washed with cold methyl tert-butyl ether, water-extracted, lyophilized and purified by reverse-phase HPLC using an Ultrasphere-ODS Cls column (10 x 150 mm) with a linear gradient of water/35 % acetonitrile in 0.1% trifluoroacetic acid. The purity of the peptide was assessed to be more than 95 % by reverse-phase HPLC analysis on an Ultrasphere-ODS C1, column (4.6 x 150 mm). Amino acid analysis, performed on a Beckman 6300 amino acid analyser gave the expected composition. Fast atom bombardment mass spectrometry yielded the following result: m/z 1731.2 (calculated 1731-1). Due to the low solubility of the peptide in aqueous buffers, a 6 mg/ml stock solution of the peptide in dimethyl sulphoxide (DMSO) or trifluoroethanol (TFE) was kept at -20 °C and used in the various assays described in this work. The final organic solvent concentration was always kept under 2 % (v/v) and had no measurable effect on vesicle stability. A peptide with the sequence ATPAKSEATPAKSE, synthesized as described above, was used as a control. At the concentration used (0-70 [aM) this peptide had no measurable effect on any of the assays performed.
Vesicle preparation. In all cases a lipid film was obtained by drying a chloroform solution of the lipid under a current of nitrogen; this film was kept under vacuum overnight. The phospholipids were resuspended at a concentration of 1 mg/ml in medium buffer (100 mMNaC1, 5 mM-MES, 5 raM-sodium citrate, 5 mM-Tris, 1 mM-EDTA) at the appropriate pH value for 1 h at 37 °C and eventually vortexed vigorously. This suspension was sonicated in a bath sonicator (Branson 1200), and was subsequently subjected to four cycles of extrusion in an Extruder apparatus (Lipex Biomembranes Inc.) with 100 nm polycarbonate filters (Costar). When encapsulation was necessary, an additional step of four freeze-thawing cycles was included after the sonication process (see below). A 0.14 mM final phospholipid concentration was used in all the experiments.
Vesicle aggregation. The change in OD360 produced by addition of the peptide from a concentrated stock solution in DMSO to a phospholipid vesicle suspension, in medium buffer at the appropriate pH, was measured on a Beckman DU-7 spectrophotometer after incubation for 1 h at 37 °C. The concentration of DMSO was kept below 1%. Samples containing equal amounts of DMSO but in the absence of peptide were always used as a control. The final phospholipid concentration was 0'14 mM.
LipM mixing assay. This was monitored by using the classical fluorescent probe dilution assay (Struck et al., 1981) , in which the decrease in efficiency of the fluorescence energy transfer between NBD-PE (energy donor) and Rh-PE (energy acceptor) incorporated into liposomes, as a consequence of lipid mixing, is monitored. Liposomes, in medium buffer at the appropriate pH, labelled with 1 tool % NBD-PE and either 0.8 or 0-6 tool % Rh-PE (depending on whether asolectin phospholipids or PS, respectively, were used) were mixed in a 1 : 9 molar ratio with unlabelled liposomes. Lipid mixing was initiated by addition of the peptide from a stock solution in TFE. The concentration of TFE was kept below 1%. The samples were incubated for 1 h at 37 °C and the emission spectra were recorded in a SLM Aminco 8000 spectrofluorimeter, with the excitation wavelength set at 450 nm. Both the excitation and emission slits were set at 4 nm. The excitation polarizer was kept constant at 90 ° and the emission polarizer was kept constant at 0 ° to minimize dispersive interference. The efficiency of energy transfer was calculated from the ratio of the emission intensities at 530 and 585 nm and the appropriate calibration curve. The final phospholipid concentration was 0.14 mM.
Release of aqueous contents. Leakage was determined by the ANTS/DPX assay (Ellens et al., 1985) which is based on the dequenching of ANTS fluorescence caused by its dilution upon release of the aqueous contents of a vesicle population containing both ANTS and DPX. The assay was performed by coencapsulating 12.5 mM-ANTS and 45 mM-DPX with 20 mM-NaC1, 10 mM-Tris, pH 7.2, in either PS or asolectin phospholipid vesicles. The lipid film was vortexed and the vesicles were sonicated in a bath for 30 rain. Afterwards, the vesicles were subjected to four cycles of freeze-thawing in liquid nitrogen and passed at least four times through an Extruder apparatus (Lipex Biomembranes Inc.) with 100 nm polycarbonate filters (Costar). After the vesicles with the coencapsulated probe and quencher had been formed, the whole sample was passed through a Sephadex G-75 column (Pharmacia) to separate the vesicles from the nonencapsulated material using medium buffer for elution (Diizgiines & Shavnin, 1992) . The final phospholipid concentration in the assay was 0.14 mM and medium buffer at the appropriate pH value was used in all cases. Leakage was initiated by addition of the peptide from a stock solution in DMSO. The concentration of DMSO was kept below 1%. The fluorescence scale was set to 100 % by addition of 0'5 % Triton X-100 and a 0 % leakage value was obtained by measuring the fluorescence of the control vesicles after the addition of DMSO. The suspensions were excited at 385 nm and ANTS emission was monitored at 520 nm. Both the excitation and emission slits were set at 4 nm. The excitation polarizer was kept constant at 90 ° and the emission polarizer was kept constant at 0 ° to minimize dispersive interference.
Haemolysis. Immediately before their use, human red blood cells were obtained from a healthy volunteer by vein puncture. Haemolysis buffers were 20 mM-Tris, 116 mM-NaC1, pH 7.3; 10 mM-Tris, 10 mMsodium acetate, 116 mM-NaCI, pH 6'0; and 20 mM-sodium acetate, 116 mM-NaCI, pH 5.0. Erythrocytes were washed four times in the appropriate buffer and diluted 100-fold in the same buffer. Increasing amounts (up to 120 ~tg) of the peptide (in DMSO) were added to 1 ml of a suspension of red blood cells solution and the mixture was allowed to react for 1 h at 37 °C with constant shaking to avoid sedimentation. Each sample was spun in a Beckman microfnge for 3 min and the absorbance of the supernatant was measured in a Beckman DU-7 spectrophotometer. Control experiments were performed with DMSO at the three pH values. The final DMSO concentration was always under 2 % (v/v). Haemolysis was monitored as the increase in A~41 : a 100 % haemolysis value was obtained by addition of Triton X-100 and a 0 % haemolysis value was obtained from control tubes containing equivalent quantities of DMSO but no peptide.
Secondary structure prediction. This was done through the e-mail network by the Profile network prediction HeilDelberg (PHD) method developed by Rost & Sander (1993) . This method relies on a system of neural networks and gives the highest normalized accuracy, better than 70 %, when cross-validated on more than 100 unique globular proteins.
Results

Vesicle aggregation
We have previously shown that a 16 amino acid peptide corresponding to the amino-terminal region of the S protein of HBV is able to interact with soybean asolectin phospholipids, leading to the formation of peptidephospholipid complexes which can be isolated on a stepwise sucrose gradient (Rodriguez-Crespo et al., lipid, PS. However, the vesicle-vesicle interactions that lead to the appearance of vesicle aggregates did not take place with neutral phospholipids, indicating the specificity of the peptide-phospholipid interaction and the importance of the electrostatic components.
Lipid mixing
The amino-terminal peptide was also able to induce phospholipid mixing between a population of vesicles containing the fluorescent probes NBD-PE and Rh-PE and probe-free vesicles (Struck et al., 1981) . The results obtained with asolectin phospholipids and PS are depicted in Fig. 2 . The final extent of lipid mixing was dose dependent and was substantially greater at acidic pH. However, at neutral pH a substantial proportion of lipid mixing could be observed. The difference observed between asolectin phospholipids and PS could be due to the presence in the former of phosphatidylethanolamine (39 %) (Papini et al., 1987) , which has been shown to form non-lamellar lipid structures and to enhance the fusion process when it is inserted in the lipid bilayer (Verkleij, 1984) .
The fact that the observed change in resonance energy transfer (from 96 % to 18 % for asolectin phospholipids or from 85% to 22% for PS, at pH 5.0 and 521aM-peptide) represents a decrease in the acceptor surface density of approximately 10-and 6-fold, respectively, would indicate that the amino-terminal peptide had induced the complete fusion of labelled and unlabelled vesicles. The mere aggregation of vesicles would not result in such a change in energy transfer (Blumental et al., 1983) . Moreover, lipid mixing is a reliable indicator of fusion when using the probe dilution assay (Diizgtines et al., 1987) .
There seems to be a clear preference for destabilization of acidic phospholipids or at least mixtures where they were present since when the ability of the peptide to induce lipid mixing of PC vesicles was monitored, no decrease of energy transfer was observed at either pH. A negatively charged phospholipid fusion dependence was also found for the amino-terminal peptide of the G protein of vesicular stomatitis virus (Diizgiines & Shavnin, 1992) . This seven amino acid peptide possesses a Lys residue at the first position followed by several hydrophobic residues. Surprisingly, mutation of the amino-terminal lysine to glutamic acid does not affect the cell~zell fusion activity of the G protein when expressed in cultured cells (Woodget & Rose, 1986) . It may be that the hydrophobic amino acids of the fusion peptide are more important in the membranedestabilizing processes than the polar residues.
Release of aqueous content
The ability of the peptide to destabilize the lipid bilayer was assessed by measuring the release of the aqueous contents of phospholipid vesicles. Liposome leakage was monitored by the dilution of coencapsulated ANTS and DPX, which leads to a rapid increase in ANTS fluorescence at 520 nm (Ellens et at., 1985) . Fig. 3 shows the leakage induced by the synthetic peptide added to a soybean asolectin phospholipid suspension. At the three pH values tested, the peptide was able to induce a rapid leakage of the internal contents of the liposomes in a dose-dependent manner. Again, the percentage leakage increased as the pH decreased. The results obtained for asolectin phospholipid and PS were similar. However, the peptide did not destabilize the bilayer ofphospholipid vesicles composed of pure PC. The amino-terminal peptide was also tested for its capacity to bring about coalescence of the internal aqueous space of liposomes, using the ANTS-DPX assay but encapsulating ANTS and DPX in separate populations of vesicles. Mixing of the inner aqueous contents occurring during fusion of vesicles would result in a decrease in fluorescence intensity. The peptide was unable to induce mixing of the contents of either asolectin phospholipids or PS under the same conditions in which noticeable lipid mixing occurs. A positive control was obtained by adding CaC12 at a concentration of 5 mra. Addition of the peptide to this control sample caused a considerable decrease in the Ca2+-induced liposome fusion, probably due to a competition between leakage and fusion. In fact, as previously observed for vesicular stomatitis virus G protein fusion peptide (Dtizgiines & Shavnin, 1992) , rapid leakage might preclude the intermixing of aqueous contents.
Haemolytic activity
To further analyse the membrane destabilization properties of the peptide, we also studied its haemolytic activity. The results of haemolysis experiments carried out at 70 I~M-peptide are shown in Fig. 4 . The amino-terminal peptide was able to interact with human red blood ceils as monitored by the increase in A541. The haemolytic activity at pH 5"0 was almost 10-fold that observed at pH 7.3. Protonation of glutamic acid at position two might be an indispensable requirement in order to obtain the complete insertion in the erythrocyte bilayer that precedes red blood cell damage and the haemoglobin leakage. At the concentration employed in the assay (70 ~tM), the anaino-terminal peptide proved to be a potent haemolysin. The haemolytic activity was dose dependent (data not shown).
Discussion
Our results, taken together, indicate that the synthetic peptide might be a useful model to study the interaction with cellular membranes of the surface glycoproteins of Fig. 5 . Amino acid sequences of the aminoterminal regions of the S proteins of different members of the hepadnavirus family. The hydrophobic putative fusion peptide is followed by heptad repeats with a sequence periodicity 'abcdefg'. The hydrophobic positions a and d within the heptad repeats, indicated by arrows, are in bold. The secondary structure predicted according to the PHD method (Rost & Sander, 1993 ) is shown below each sequence. The elements of secondary structure are: H (helix) or L (loop). '.' means that no prediction is made for this residue. References for the sequences are: HBV (subtype ayw) (Okamoto et al., 1986) ; WHV and DHBV (Mandart et al., 1984) ; GSHV (Seeger et al., 1984) .
HBV. The amino-terminal peptide was able to induce vesicle aggregation, lipid mixing, rapid leakage of trapped fluorescent probes as well as lysis oferythrocytes. The lipid vesicle destabilization induced by the peptide is dependent on the amount of added peptide as well as requiring an acidic pH. The pH dependence of the fusogenic properties of the peptide might indicate that, in vivo, infection might proceed through receptor mediated endocytosis. If this explanation is correct, a conformational change in the viral envelope glycoproteins induced by the acidic pH, followed by the protonation of the glutamic acid residue at position two of the S protein, might be a prerequisite for membrane insertion and destabilization. However, this particular glutamic acid residue is not conserved among hepadnaviruses. This fact might point to the greater importance of the hydrophobic residues of this fusion peptide (with the Phe-Leu-Gly-tripeptide being especially important) compared to the glutamic acid residue. All the assays performed with liposomes must take into account the limitations imposed by these studies. In this regard, HIV and simian immunodeficiency virus, which are known to enter CD4 + cells by fusing with the plasma membrane at neutral pH, have significantly enhanced fusogenic properties when interacting with liposomes at acidic pH (Larsen et al., 1990 (Larsen et al., , 1993 . The physiological significance of this increased fusogenic capacity is doubtful. Similarly, the most important aspect of the studies described in this paper is the membrane destabilizing properties of the peptide both at neutral and acidic pH values; however, a direct correlation with the fusion process in vivo is not possible.
Activation of the fusogenic properties of hepadnavirus might proceed through either proteolytic cleavage or by low pH conformational changes induced in liposomes, as generally accepted for other viruses. In this regard, trypsin and V8 protease treatment of HBsAg particles (which removes the preS2 attachment site) increases the binding of the particles to HepG2 cells, HeLa cells and fibroblasts (Gerlich et al., 1993) , while this same treatment performed on recombinant HBsAg particles that lack the preS2 sequence does not induce any binding to the cell lines tested. A possible explanation of this fact might be a different exposure of the S protein amino terminus in recombinant particles and after removal of the preS2 domain by proteolytic cleavage with either of the two proteases (Gerlich et al., 1993) . The way in which this fusion sequence becomes exposed in vivo requires further studies.
A more detailed inspection of the S protein of HBV has revealed the presence of another sequence motif that further confirms the role of this peptide in fusogenic processes. Most of the fusion peptides located in the amino-terminal regions of several virus envelope glycoproteins are followed by heptad repeats of hydrophobic amino acids that in some cases are supposed to be folded into coiled-coils (Chambers et al., 1990) . Influenza virus haemagglutinin is assumed to fuse with the endosome membrane by means of a spring mechanism in which a long three-stranded coiled-coil would send the fusion peptide toward the target membrane when the low pH conformational change occurs (Carr & Kim, 1993) . Equally, a synthetic peptide of HIV gp41 contiguous to the fusion peptide is able to adopt, under physiological conditions, a long parallel a-helix characteristic of a coiled-coil or a leucine-zipper (Wild et al., 1992) . Though the exact function of this succession of hydrophobic amino acid heptads is not clear, this sequence motif has been also found recently in non-viral fusogenic proteins (S611ner et al., 1993) . Fig. 5 shows the amino acid sequences of the aminoterminal regions of the S protein of HBV (subtype ayw) and other members of the hepadnavirus family. In all cases the amino-terminal hydrophobic stretch, where the putative fusion peptide is located, is followed by a region which consists of heptad repeats of amino acids. These show a sequence periodicity 'abcdefg', in which the side-chains of amino acids in positions 'a' and 'd' are bulky and hydrophobic. If the region including the heptad repeats adopts an e-helical structure, two of these helices could interact lengthwise by pairing hydrophobic residues located in positions 'a' and 'd'. The secondary structure of the S protein amino-terminal sequences of HBV, GSHV, WHV and DHBV predicted by means of the PHD method, which relies on a system of neural networks (Rost & Sander, 1993) , is also shown in Fig. 5 . For all the sequences analysed the heptad repeats are predicted as a long a-helix. This is particularly surprising for HBV since this helix might be interrupted by a proline residue. Hence, the heptad repeats may indeed be folded as inter-subunit ~-helical coiled-coils which could function in virus entry and cell fusion (Chambers et al., 1990) .
In conclusion, the amino-terminal peptide of the S protein has been shown to induce aggregation, close apposition of membranes and destabilization of the bilayers, the essential steps required for fusion (Bentz et al., 1983) . These results support the idea that this region of the S protein plays an active role in the viral fusogenic processes and, then, might be considered as an important target in the design of immunological strategies for the prevention of HBV infection in vivo. Site-directed mutagenesis performed on a suitable in vitro infective system could be very valuable to confirm the results of our experiments.
